These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4170980)

  • 1. Tolbutamide and propranolol.
    De Divitiis O; Giordano F; Gallo B; Jacono A
    Lancet; 1968 Apr; 1(7545):749. PubMed ID: 4170980
    [No Abstract]   [Full Text] [Related]  

  • 2. [Propranolol and hypoglycemic sulfonamides. Study on insulin secretion and blood sugar].
    Loubathières A; Mariani MM; Ribes G; Chapal J
    C R Seances Soc Biol Fil; 1971; 165(6):1393-7. PubMed ID: 4262051
    [No Abstract]   [Full Text] [Related]  

  • 3. Propranolol does not inhibit sulphonylurea-stimulated insulin secretion in patients with non-insulin dependent diabetes mellitus.
    Groop L; Tötterman KJ
    Acta Endocrinol (Copenh); 1982 Jul; 100(3):410-5. PubMed ID: 7051722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of insulin secretion by aryl-substituted secondary aminoethanols.
    Bressler R; Vargas-Cordon M; Brendel K
    Diabetes; 1969 May; 18(5):262-7. PubMed ID: 4307639
    [No Abstract]   [Full Text] [Related]  

  • 5. Depressed tolbutamide-induced insulin response in subjects treated with propranolol.
    Massara F; Strumia E; Camanni F; Molinatti GM
    Diabetologia; 1971 Aug; 7(4):287-9. PubMed ID: 5093710
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of propranolol on the hypoglycemic action of insulin and tolbutamide in diabetic patients].
    Kowalski S; Wolański A
    Pol Arch Med Wewn; 1969; 42(1):55-61. PubMed ID: 5767511
    [No Abstract]   [Full Text] [Related]  

  • 7. [Autonomic nervous system and secretion of insulin. II. Effect of adrenergic blockaders on the insulin secretion in response to tolbutamide].
    Carducci Artenisio A; Albanese MC; Allegra V; Alibrando S; Sprovieri M; Caruso A; Corsi V
    Folia Endocrinol; 1972 Dec; 25(6):467-85. PubMed ID: 4354623
    [No Abstract]   [Full Text] [Related]  

  • 8. [Influence of propranolol on the action of tolbutamide].
    Specchia G; Fratino P; Gamba G
    Boll Soc Ital Biol Sper; 1970 Jun; 46(12):586-9. PubMed ID: 5496525
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of propranolol on HGH secretion after endovenous tolbutamide load in obese subjects.
    Carducci Artenisio A; Sprovieri M; Albanese MC; Allegra V; Ragonese F; Corsi V
    Horm Metab Res; 1973 Nov; 5(6):473-4. PubMed ID: 4767004
    [No Abstract]   [Full Text] [Related]  

  • 10. Hyperresponsiveness to tolbutamide of dogs pretreated with diazoxide.
    Anderson JH; Byrd GW; Blackard WG
    Metabolism; 1971 Nov; 20(11):1023-30. PubMed ID: 4329940
    [No Abstract]   [Full Text] [Related]  

  • 11. [Insulin secretion study during arginine perfusion. Comparative effects of sympatholytics in normal subjects and hyperthyroid patients].
    Modigliani E; Strauch G; Delzant G; Gilbert-Dreyfus
    Rev Fr Etud Clin Biol; 1969 Mar; 14(3):267-75. PubMed ID: 5790135
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mechanism of insulin secretion with special regard to prediabetes].
    Cerasi E; Luft R
    Tidsskr Nor Laegeforen; 1971 Nov; 91(17):1287-93. PubMed ID: 4327787
    [No Abstract]   [Full Text] [Related]  

  • 13. On the action of tolbutamide in normal man. I. Role of adrenergic mechanisms in tolbutamide-induced insulin release during normoglycaemia and induced hypoglycaemia.
    Widström A; Cerasi E
    Acta Endocrinol (Copenh); 1973 Mar; 72(3):506-18. PubMed ID: 4739358
    [No Abstract]   [Full Text] [Related]  

  • 14. [Recent pharmacologic aspects of sulfamides modifying insulin secretion (hypoglycemic and hyperglycemic sulfamides)].
    Loubatiéres A; Mariani MM
    Actual Physiol Pathol (Paris); 1973; 4():237-66. PubMed ID: 4219256
    [No Abstract]   [Full Text] [Related]  

  • 15. Insulin response to glucose and tolbutamide in "essential" versus "pancreatic" mild glucose intolerance.
    Vague P; Ramahandridona G; Gerolami A
    Diabetes; 1974 Nov; 23(11):896-901. PubMed ID: 4430416
    [No Abstract]   [Full Text] [Related]  

  • 16. Biological activities of tolbutamide and its metabolites. A dissociation of insulin-releasing and hypoglycemic activity.
    Feldman JM; Lebovitz HE
    Diabetes; 1969 Aug; 18(8):529-37. PubMed ID: 5808747
    [No Abstract]   [Full Text] [Related]  

  • 17. Potentiation of tolbutamide-mediated insulin release in adult onset diabetics by methysergide maleate.
    Baldridge JA; Quickel KE; Feldman JM; Lebovitz HE
    Diabetes; 1974 Jan; 23(1):21-4. PubMed ID: 4588670
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the role of adenylcyclase in insulin secretion.
    Bressler R; Cordon MV; Brendel K
    Arch Intern Med; 1969 Mar; 123(3):248-51. PubMed ID: 4303991
    [No Abstract]   [Full Text] [Related]  

  • 19. Potentiation of insulin secretion in vitro by serotonin antagonists.
    Feldman JM; Quickel KE; Lebovitz HE
    Diabetes; 1972 Jul; 21(7):779-88. PubMed ID: 4402679
    [No Abstract]   [Full Text] [Related]  

  • 20. No effect of propranolol and metoprolol on tolbutamide-stimulated insulin-secretion in hypertensive diabetic and non-diabetic patients.
    Tötterman KJ; Groop LC
    Ann Clin Res; 1982 Aug; 14(4):190-3. PubMed ID: 6762846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.